EUVIMEDEUVIMED entdecken
Vergleichsstudie

Voxel-Level Comparison of [ 18 F]CETO and [ 11 C]MTO for Molecular Imaging of Primary Aldosteronism

Daniel Gillett, James MacFarlane, Emily Goodchild, Xilin Wu, Jessica Kearney, Kate Laycock, Francesca Leek, Rosy Crawford, Safia Spink, Russell Senanayake, Ines Harper, Iosif A Mendichovszky und 6 weitere

Journal of Nuclear Medicine Technology · 2025

DOI: 10.2967/jnmt.125.270687 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nuclear Medicine Technology, 2025. Verfasst von Daniel Gillett und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; dg538@cam.ac.uk mg299@medschl.cam.ac.…. Hauptthemen laut MEDLINE: Hyperaldosteronism, Carbon Radioisotopes, Etomidate, Molecular Imaging. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary aldosteronism (PA), which accounts for up to 14% of all hypertension cases and 25% of treatment-resistant hypertension cases, may be caused by unilateral or bilateral adrenal gland pathology. The identification of patients who are most likely to benefit from targeted intervention (i.e., adrenalectomy or nodule ablation) remains a challenge. Adrenal vein sampling is an invasive procedure with restricted availability, and recent studies have found that its accuracy in predicting surgical cure may be lower than previously thought. Molecular imaging with [11C]metomidate ([11C]MTO) PET is a noninvasive alternative, but the short half-life of 11C prevents its widespread use. A novel fluorinated radiotracer, para-chloro-2-[18F]fluoroethyletomidate ([18F]CETO), has the potential to address this limitation because of its longer half-life. Initial reports suggest that [18F]CETO and [11C]MTO have very similar visual (qualitative) appearances in patients with adrenal gland tumors.

Methods

Using individual voxel measurements, we compared [18F]CETO and [11C]MTO uptake in the adrenal glands of 31 patients with PA who were recruited to the extension phase of the MATCH clinical trial.

Results

Qualitative comparisons of [18F]CETO and [11C]MTO images showed comparable adrenal gland uptake, although [11C]MTO demonstrated greater liver uptake, which obscured the right adrenal gland in some patients. Voxelwise comparisons yielded high correlation coefficients for both the left (r = 0.89) and right (r = 0.87) adrenal glands, which were statistically significant (P < 0.001). Bland-Altman analyses revealed mean SUV differences of 0.71 (CI, -6.09 to 7.51) for the left adrenal gland and 2.55 (CI, -5.91 to 11.00) for the right adrenal gland, indicating no significant bias between radiotracers. Conclusion: [18F]CETO and [11C]MTO show remarkable similarity when used for molecular imaging in patients with PA. Notably, the right adrenal gland is more readily visualized with [18F]CETO, attributed to lower hepatic uptake. These findings, coupled with the longer half-life of 18F, should enable wider access to molecular imaging of the adrenal glands.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismCarbon RadioisotopesEtomidateMolecular ImagingHumansMaleMiddle AgedFemaleAdultAgedPositron-Emission TomographyAdrenal Glands

Stichwörter der Autor:innen

PET/CT[11C]MTO[18F]CETOendocrineimage processingprimary aldosteronism

Substanzen

Carbon RadioisotopesEtomidatemetomidateCarbon-11

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; dg538@cam.ac.uk mg299@medschl.cam.ac.uk.
  • Cambridge Endocrine Molecular Imaging Group, University of Cambridge, Cambridge, United Kingdom.
  • Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • NIHR Barts Cardiovascular Biomedical Research Centre, Barts, United Kingdom, and London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
  • Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

Zitieren

APA

Gillett, D., MacFarlane, J., Goodchild, E., Wu, X., Kearney, J., Laycock, K., Leek, F., Crawford, R., Spink, S., Senanayake, R., Harper, I., Mendichovszky, I. A., Aloj, L., Cheow, H., Aigbirhio, F. I., Drake, W. M., Brown, M. J., & Gurnell, M. (2025). Voxel-Level Comparison of [ 18 F]CETO and [ 11 C]MTO for Molecular Imaging of Primary Aldosteronism. Journal of Nuclear Medicine Technology. https://doi.org/10.2967/jnmt.125.270687

Vancouver

Gillett D, MacFarlane J, Goodchild E, Wu X, Kearney J, Laycock K, et al. Voxel-Level Comparison of [ 18 F]CETO and [ 11 C]MTO for Molecular Imaging of Primary Aldosteronism. Journal of Nuclear Medicine Technology. 2025. doi:10.2967/jnmt.125.270687

BibTeX
@article{Gillett2025,
  author = {Gillett, Daniel and MacFarlane, James and Goodchild, Emily and Wu, Xilin and Kearney, Jessica and Laycock, Kate and Leek, Francesca and Crawford, Rosy and Spink, Safia and Senanayake, Russell and Harper, Ines and Mendichovszky, Iosif A and Aloj, Luigi and Cheow, Heok and Aigbirhio, Franklin I and Drake, William M and Brown, Morris J and Gurnell, Mark},
  title = {Voxel-Level Comparison of [ 18 F]CETO and [ 11 C]MTO for Molecular Imaging of Primary Aldosteronism},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2025},
  doi = {10.2967/jnmt.125.270687}
}
Kostenlos starten →